NeoStrata Redness Neutralizing Serum

0

*Sponsored Post*

This lightly cooling NeoStrata Redness Neutralizing Serum is formulated with NeoStrata BioCalm Complex™, a proprietary blend of ingredients to target the sources of redness, restore and strengthen the skin’s protective barrier and help calm skin prone to sensitivity, such as rosacea-prone skin.

NeoStrata BioCalm Complex™ features bio-active benefit ingredients to help interrupt the inflammation cascade, improve skin resiliency and reduce the appearance of flushing, while decreasing the potential for future redness-inducing triggers.

A patented Bionic/PHA formula helps restore and strengthen skin’s protective barrier, while calming irritated skin and reducing redness. Vitamin E and White Tea Extract, potent antioxidants, help defuse UV induced damage caused by oxidative stress. As a result, skin is calm and redness is neutralised.

Recommended Usage: Twice Daily AM/PM

Key Ingredients: Lactobionic Acid, Gluconolactone

Directions: Smooth on clean skin twice a day. Can be layered under a moisturizer.

Clinical Results:

  • 92% of participants noted skin is less red after 2 weeks of twice daily application
  • 67% of participants noted skin is less red 2 hours after application
  • 83% of participants noted serum is soothing at 2 hours after application

How much does it cost?

From R855.00

Where can I buy it?

NeoStrata is available at a range of aesthetic clinics and doctors nationwide, visit www.genop.co.za to find a stockist near you.

Products can also be ordered online from: www.dermastore.co.za or www.skinmiles.com

Get in touch with NeoStrata South Africa

Website: www.genop.co.za

Facebook: www.facebook.com/NeoStrataSA

Instagram: www.instagram.com/neostratasa

NeoStrata is distributed in South Africa by Genop Healthcare

Share.

About Author

Rochelle is co-owner of A2 Aesthetic & Anti-Ageing Magazine - she looks after A2's Blog and the Sales & Marketing for the A2 Print Magazine. Follow her on twitter by clicking the birdy on the top right of this block.

Comments are closed.